Key Highlights

  • Wix.com reported second-quarter Revenue of $563 million, up 15% year over year, with its Base44 AI app-building platform reaching roughly $150 million in ARR by May 2026.
  • i3 Verticals grew ARR from continuing operations 8.3% to $174.1 million even as it trimmed full-year revenue guidance to $221 million from $229 million.
  • OptimizeRx's revenue fell 30% year over year to $20.5 million, with net revenue retention dropping to 90% from 121%, even as the company posted non-GAAP Net Income of $3.1 million.
  • Aether Holdings disclosed substantial doubt about its ability to continue as a going concern, with cash falling to roughly $0.8 million from $4.4 million over six months.

Grouping five companies under one headline is a convenience, not a thesis. Beamr Imaging (NASDAQ:BMR), Wix.com (NASDAQ:WIX), Aether Holdings (NASDAQ:ATHR), i3 Verticals (NASDAQ:IIIV) and OptimizeRx (NASDAQ:OPRX) sit at opposite ends of the size and quality spectrum, from a profitable multibillion-dollar SaaS platform to a micro-cap that has told investors it may not survive without fresh funding.

What ties them together is the screen many US investors are running this month: Nasdaq-listed software and technology-services names where an AI storyline is colliding with a suddenly less friendly rate backdrop. Reporting on the early-September session noted that August payrolls came in near 162,000 jobs versus expectations closer to 55,000, and that traders lifted the odds of a Federal Reserve rate hike in September to roughly 58% on CME Group data. That is the opposite of the rate-cut tailwind software bulls spent 2024 and 2025 counting on.

A Hawkish Turn Reframes the AI Trade

Higher-for-longer, or higher-from-here, rates compress the present value of distant cash flows, precisely the profile of unprofitable story stocks. It rewards companies that can show real revenue, margins and cash generation today, and punishes those still asking investors to fund the gap between an AI narrative and an income statement.

That split is the useful lens for these five. Wix and i3 Verticals generate cash. OptimizeRx is profitable on an adjusted basis but shrinking. Beamr and Aether are pre-scale, and one of them carries an explicit going-concern warning. In a hawkish tape, those distinctions matter more than the shared AI, software and technology services label.

Beamr Imaging (NASDAQ:BMR): Compression Tech Hunting a Physical-AI Catalyst

Beamr Imaging is an Israel-based video-compression company built on content-adaptive compression, holding 53 patents and an Emmy Award for technology and engineering. In its first-quarter 2026 update, reported May 27, 2026, Beamr posted revenue of about $0.63 million, roughly flat year over year, with $9.6 million in cash and deposits as of March 31, 2026. It renewed contracts with JioHotstar and most major media customers, and demonstrated with VAST Data at NVIDIA GTC 2026.

The more interesting pivot is toward physical AI. Beamr reported 10 active proofs of concept with autonomous-vehicle firms and cited testing with dSPACE showing 31% file-size reduction versus baseline encodes and machine-learning-safe compression, plus a new VISTA platform for large-scale video-quality testing.

The appeal is a large, data-heavy adjacency, autonomous-vehicle and robotics teams drowning in sensor video. The risk is equally clear: revenue is tiny, and proofs of concept are not contracts. The stock is a binary bet on converting one or two lighthouse accounts into recurring commercial deals.

Wix.com (NASDAQ:WIX): The Cash-Generative Way to Own the AI Website Theme

Wix.com, a US-listed, Israel-based website-building SaaS company, reported second-quarter 2026 results on August 4, 2026 with revenue of $563 million, up 15% year over year. It counted roughly 317 million registered users and generated an 11% free-cash-flow Margin in the quarter, and reiterated full-year 2026 guidance for revenue growth in the low-to-mid-teens.

Base44, the AI app-building platform Wix acquired in June 2025, reached roughly $150 million in ARR by May 2026. During the quarter Wix launched Base1, a proprietary large language model, plus Superagents, and projected Base44 approaching 60% non-GAAP gross margin in the second half of 2026.

This is the highest-quality name in the group and arguably the cleanest way to hold the AI-eats-website-creation thesis without betting on a pre-revenue story. Wix already earns cash while it invests in AI, which matters in a hawkish tape. The debate is whether AI expands Wix's market or commoditizes DIY site-building; Base1 gives Wix cost control over inference, a genuine margin lever if Base44 scales.

Aether Holdings (NASDAQ:ATHR): A Micro-Cap Sentiment Play With a Going-Concern Flag

Aether Holdings is a New York Fintech whose flagship product, SentimenTrader.com, sells market-sentiment analytics, research and tools to traders. It completed its IPO on April 10, 2025 at $4.30 per share. Per its most recent quarterly filing, covering the six months ended March 31, 2026, revenue was about $675,000, roughly flat, against a net loss near $2.3 million, with cash falling to roughly $0.8 million from $4.4 million.

Management disclosed substantial doubt about the company's ability to continue as a going concern, and after the period issued a $3.24 million secured note at 8% interest. Aether has also launched Aether Labs, an AI-focused R&D unit, and AetherHub, a data-labeling joint venture with OorTech.

This is the group's most fragile name. A going-concern warning, heavy cash burn, seven employees and a share count that IPO'd only last year make ATHR a high-risk micro-cap, not a core holding. The AI-analytics angle is real but unproven at this scale.

i3 Verticals (NASDAQ:IIIV): A Slower, Steadier Public-Sector Software Story

i3 Verticals has reshaped itself into a pure-play public-sector and education software company after divesting merchant services in September 2024 and healthcare RCM in May 2025, now serving courts, public safety, transportation, utilities and schools. In fiscal third-quarter 2026 results, filed August 6, 2026, revenue was $53.1 million, up 2.2%, while ARR from continuing operations grew 8.3% to $174.1 million and adjusted EBITDA rose 4.6% to $13.3 million, a 25.1% margin.

Management trimmed full-year 2026 guidance to revenue of $221 million, from $229 million, and adjusted EBITDA of $60 million, from $65 million, citing weakness in non-recurring revenue and implementation delays, while flagging four statewide transportation services going live.

The recurring engine, sticky, mission-critical government software, is growing at a healthy clip even as headline revenue drags. The guidance cut is a reminder that lumpy, non-recurring streams and slow public-sector implementations can mask the underlying model.

OptimizeRx (NASDAQ:OPRX): Profitable but Shrinking in Healthcare Marketing Tech

OptimizeRx connects pharmaceutical companies with clinicians and patients through AI-enabled engagement platforms. In second-quarter 2026 results, reported August 12, 2026, revenue fell 30% year over year to $20.5 million, producing a GAAP net loss of $0.7 million but non-GAAP net income of $3.1 million and adjusted EBITDA of $4.9 million. Net revenue retention dropped to 90% from 121%, and average revenue per top-20 pharma client slipped to $2.66 million. Cash stood at $24.1 million, and the company completed a $35 million Debt refinancing. OptimizeRx reaffirmed full-year 2026 guidance of $100 million in revenue and $25 million in adjusted EBITDA.

The story here is a profitable Business fighting a Demand air-pocket. Sub-100% retention is the number that should worry investors most, it signals clients spending less, not just fewer new logos. The bull case rests on stabilizing retention and re-accelerating pharma marketing budgets; the bear case is that the shrinkage is structural.

What Investors Should Watch

For Wix, the second-half 2026 Base44 gross-margin path and whether AI broadens the funnel. For i3 Verticals, ARR growth versus reported revenue and implementation timing. For OptimizeRx, net revenue retention above all. For Beamr, any conversion of autonomous-vehicle proofs of concept into signed, recurring contracts. For Aether, simple survival: cash runway, dilution and the going-concern status.

Across all five, the shared macro variable is rates. If September's hawkish shift hardens into actual hikes, unprofitable names face the stiffest headwind, while cash-generative software should prove more defensible.

Proven Cash Flow Versus Everything Still Running on Narrative

These five names are not a basket to buy together. Wix is the quality anchor; i3 Verticals is a slower, recurring-revenue rebuild; OptimizeRx is a profitable turnaround with a retention problem; Beamr is a catalyst-driven micro-cap; and Aether is a speculative micro-cap carrying an explicit going-concern warning. In a month when the Fed conversation has flipped from cuts to possible hikes, the market is likely to reward proven cash flow and scrutinize everything that still runs on narrative.